Ftse Mib
35.374,00
-0,10%
DAX
18.648,17
-0,41%
S&P 500
5.297,10
-0,21%
NASDAQ
16.698,32
-0,26%
Bitcoin
66.092,13
1,31%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Stemline Therapeutics Inc (STML) Stemline Therapeutics Inc (STML) Notizie

STML

Stemline Therapeutics (STML)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:STML
DataOraFonteTitoloSimboloCompagnia
12/02/202122:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:STMLStemline Therapeutics Inc
22/06/202015:52Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:STMLStemline Therapeutics Inc
17/06/202012:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STMLStemline Therapeutics Inc
10/06/202018:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017:51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STMLStemline Therapeutics Inc
10/06/202017:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STMLStemline Therapeutics Inc
10/06/202016:20Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:STMLStemline Therapeutics Inc
10/06/202016:05Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STMLStemline Therapeutics Inc
10/06/202016:05Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STMLStemline Therapeutics Inc
10/06/202015:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STMLStemline Therapeutics Inc
15/05/202019:20PR Newswire (US)INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Enco...NASDAQ:STMLStemline Therapeutics Inc
13/05/202020:43Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:STMLStemline Therapeutics Inc
12/05/202022:22Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:STMLStemline Therapeutics Inc
12/05/202021:14Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:STMLStemline Therapeutics Inc
11/05/202022:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STMLStemline Therapeutics Inc
06/05/202001:57PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.NASDAQ:STMLStemline Therapeutics Inc
05/05/202020:23PR Newswire (US)Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law FirmNASDAQ:STMLStemline Therapeutics Inc
05/05/202018:03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:STMLStemline Therapeutics Inc
04/05/202021:09Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:STMLStemline Therapeutics Inc
04/05/202018:28PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Stemline Therapeutics Inc.NASDAQ:STMLStemline Therapeutics Inc
04/05/202017:22PR Newswire (US)Stemline Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Stemline Therapeutics, Inc. ...NASDAQ:STMLStemline Therapeutics Inc
04/05/202016:58PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Stemline Therapeutics Inc. has obtained a Fair Price in its sal...NASDAQ:STMLStemline Therapeutics Inc
04/05/202015:13PR Newswire (US)(STML) Alert: Johnson Fistel Investigates Proposed Sale of Stemline Therapeutics; Are Shareholders Getting a Fair Deal?NASDAQ:STMLStemline Therapeutics Inc
04/05/202013:00GlobeNewswire Inc.Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 MillionNASDAQ:STMLStemline Therapeutics Inc
29/04/202023:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:STMLStemline Therapeutics Inc
29/04/202023:24Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:STMLStemline Therapeutics Inc
16/03/202022:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STMLStemline Therapeutics Inc
13/03/202021:45GlobeNewswire Inc.Stemline Therapeutics Reports Fourth Quarter 2019 Financial ResultsNASDAQ:STMLStemline Therapeutics Inc
11/03/202021:05GlobeNewswire Inc.Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020NASDAQ:STMLStemline Therapeutics Inc
26/02/202013:30GlobeNewswire Inc.Stemline Therapeutics to Present at the Cowen 40th Annual Health Care ConferenceNASDAQ:STMLStemline Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:STML

La tua Cronologia

LATK
DRGNBTC
Dragonchain
BIT
F35259
Vontobel Financial Produ...
COIN
RIOEUR
BOV
BRFSQ192
BRFSQ192 Ex:19,25
COIN
LNKUSD
Link Platform
LSE
HEDG
Wt Eur Eq Gbp H
LSE
0L5V
Sherwin-williams
LSE
0MNY
Ing Bank Slaski
LSE
UF05
Citi Fun 25
BIT
F39251
Vontobel Financial Produ...
NASDAQ
FARQX
Franklin Conservative Al...
MRTX
HSNETH
Helper Search Token
NASDAQ
OLITU
OmniLit Acquisition
NYSE
C-K
Citigroup
COIN
LQTYUSD
LQTY
COIN
GALAXYUST
Galaxy Coin
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network